Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Pharmacyclics Inc

+ Add to Watchlist


261.2500 USD 1.7000 0.65%

As of 20:10:00 ET on 05/22/2015.

Company Profile for Pharmacyclics Inc (PCYC)

Pharmacyclics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. The Company's pharmaceutical drug development candidates are synthetic small-molecules designed to target key biochemical pathways involved in human diseases with critical unmet needs.

Contact Information

Pharmacyclics Inc

995 East Arques Avenue
Sunnyvale, CA 94085-4521
United States
Phone: 1-408-774-0330
Fax: 1-408-774-0340

Key Executives for Pharmacyclics Inc (PCYC)

Robert W Duggan "Bob"Chairman/CEOManmeet SoniCFO/Treasurer
Mahkam Zanganeh "Maky"Chief Operating OfficerShawn Cline TomaselloChief Commercial Officer
Jesse McGreivyChief Medical OfficerMaria FardisChief:Oncology Ops & Alliances
Heow TanChief:Quality Technical OpsRainer M Erdtmann "Ramses"Senior VP:Investor Relations
Richard Love "Rick"VP/Secretary/General CounselMatthew D OuttenVP:Commercial Operations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil